Figure 5.

Effect of Ova-related complexes on lymphocytes.

Notes: (A) Spleen-lymphocyte proliferation; (B) T-lymphocyte transformation; (C) B-lymphocyte transformation; (D) flow cytometry results of proportion of CD3⁺CD4⁺ lymphocytes; (E) flow cytometry results of proportion of CD3⁺CD8⁺ lymphocytes; (F) quantification of proportion of CD3⁺CD4⁺ lymphocytes; (G) quantification of proportion of CD3⁺CD8⁺ lymphocytes; (H) proportion of CD4⁺CD69⁺ lymphocytes. *P<0.05, **P<0.01, ***P<0.001 compared to PBS controls; ^#P<0.05, ^##P<0.01, ^###P<0.001 compared to Ova controls; ^!P<0.05, ^!!P<0.01, ^!!!P<0.001 compared to Ova + AL controls (n=3).

Abbreviations: CS, curdlan sulfate; O-HTCC, O-(2-hydroxyl)propyl-3-trimethyl ammonium chitosan chloride; Ova, ovalbumin; AL, Alhydrogel.